IC
IRWD icon

IEQ Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

IEQ Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.61M Buy
742,723
+109,463
+17% +$449K 0.01% 674
2025
Q4 		$2.13M Sell
633,260
-28,438
-4% -$73.9K 0.01% 768
2025
Q3 		$867K Buy
661,698
+169,816
+35% +$176K ﹤0.01% 1063
2025
Q2 		$353K Buy
491,882
+306,154
+165% +$240K ﹤0.01% 1321
2025
Q1 		$273K Buy
+185,728
New +$442K ﹤0.01% 1228

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

IEQ Capital's IRWD Position: Q1 2026 in Review

IEQ Capital increased its Ironwood Pharmaceuticals (IRWD) stake by 17% in Q1 2026, buying an estimated $449K and bringing the position to 742,723 shares worth $2.61M. The position accounts for 0.01% of the portfolio, ranked #674.

IEQ Capital first reported a position in IRWD in Q1 2025 and has held it in 5 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • IEQ Capital held 742,723 shares of Ironwood Pharmaceuticals worth $2.61M as of Q1 2026.
  • IEQ Capital bought 109,463 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $449K.
  • Ironwood Pharmaceuticals made up 0.01% of IEQ Capital's portfolio in Q1 2026, its #674 holding.
  • IEQ Capital first reported a position in Ironwood Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.